GRK4 Polymorphisms Blood Pressure Response to Candesartan
Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the association between GRK4 polymorphisms and
essential hypertension in southwestern Han Chinese and test whether these polymorphisms were
associated with the changes in blood pressure in patients with essential hypertension treated
with angiotensin II Type antagonist candesartan.